Loiasis: African eye worm (Q34777473)

4 August 2017

1 reference

title

Loiasis: African eye worm (English)

1 reference

4 August 2017

1 reference

Kathryn H Jacobsen

2

0 references

author name string

Jeannie J Padgett

series ordinal

1

1 reference

4 August 2017

7 May 2008

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

4 August 2017

1 reference

4 August 2017

102

1 reference

4 August 2017

10

1 reference

4 August 2017

983-989

1 reference

Loa loa in the anterior chamber of the eye: a case report

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Potential vectors of loiasis and other tabanids on the island of Bioko, Equatorial Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Ivermectin treatment of loiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Impact of repeated large scale ivermectin treatments on the transmission of Loa loa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Common occurrence of amicrofilaraemic Loa loa filariasis within the endemic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Genetic epidemiology of host predisposition microfilaraemia in human loiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Marked decrease in Loa loa microfilaraemia six and twelve months after a single dose of ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Serum immunoglobulin G4 antibodies to the recombinant antigen, Ll-SXP-1, are highly specific for Loa loa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Filariasis in travelers presenting to the GeoSentinel Surveillance Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Reduction of microfilaraemia with single high-dose of ivermectin in loiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

The life and times of ivermectin - a success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Loiasis: the individual factors associated with the presence of microfilaraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Decreased prevalence and intensity of Loa loa infection in a community treated with ivermectin every three months for two years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

IgG4 serology of loiasis in three villages in an endemic area of south-eastern Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

The occurrence of loiasis, mansonellosis and wuchereriasis in the Jarawa River Valley, central Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Filariasis due to Loa loa and Mansonella perstans: distribution in the region of Okondja, Haut-Ogooué Province, Gabon, with parasitological and serological follow-up over one year.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Chrysops silacea biting densities and transmission potential in an endemic area of human loiasis in south-west Cameroon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Heterogeneity in the prevalence and intensity of loiasis in five contrasting bioecological zones in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Markers of Loa loa infection in permanent residents of a loiasis endemic area of Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Challenges for the future: loiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Infectious diseases: filariasis, Malayan filariasis, loiasis (ioa ioa), Onchocerciasis (river blindness)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Loiasis--a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.022

10.1016/J.TRSTMH.2008.03.022

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

18466939